These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21213151)

  • 41. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on Alzheimer's disease therapeutics.
    Rafii MS
    Rev Recent Clin Trials; 2013 Jun; 8(2):110-8. PubMed ID: 23859061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular pathogenesis and development of disease-modifying drugs for Alzheimer's disease].
    Takeda M
    Seishin Shinkeigaku Zasshi; 2013; 115(1):32-40. PubMed ID: 23691792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's Disease: Advances in Drug Development.
    Piton M; Hirtz C; Desmetz C; Milhau J; Lajoix AD; Bennys K; Lehmann S; Gabelle A
    J Alzheimers Dis; 2018; 65(1):3-13. PubMed ID: 30040716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The translocator protein as a drug target in Alzheimer's disease.
    Chua SW; Kassiou M; Ittner LM
    Expert Rev Neurother; 2014 Apr; 14(4):439-48. PubMed ID: 24625007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's disease: strategies for disease modification.
    Citron M
    Nat Rev Drug Discov; 2010 May; 9(5):387-98. PubMed ID: 20431570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions.
    Abeysinghe AADT; Deshapriya RDUS; Udawatte C
    Life Sci; 2020 Sep; 256():117996. PubMed ID: 32585249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic news in Alzheimer’s disease: soon a disease-modifying therapy?].
    Villain N
    Geriatr Psychol Neuropsychiatr Vieil; 2022 Jun; 20(2):256-260. PubMed ID: 35929392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?
    Villain N
    Rev Neurol (Paris); 2022 May; 178(5):437-440. PubMed ID: 35489824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions.
    Bhat NR
    J Alzheimers Dis; 2015; 46(3):581-91. PubMed ID: 26402511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging therapeutics for Alzheimer's disease.
    Chiang K; Koo EH
    Annu Rev Pharmacol Toxicol; 2014; 54():381-405. PubMed ID: 24392696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell and gene therapy in Alzheimer's disease.
    Glat MJ; Offen D
    Stem Cells Dev; 2013 May; 22(10):1490-6. PubMed ID: 23320452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An update on treatment and prevention strategies for Alzheimer's disease.
    Neugroschl J; Sano M
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):368-76. PubMed ID: 19664366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives.
    de Castro AA; da Cunha EFF; Pereira AF; Soares FV; Leal DHS; Kuca K; Ramalho TC
    Curr Alzheimer Res; 2018; 15(12):1161-1178. PubMed ID: 30101709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug discovery for Alzheimer's disease: filling the pipeline.
    Horton AR; Fillit HM
    Curr Alzheimer Res; 2007 Dec; 4(5):501-2. PubMed ID: 18220510
    [No Abstract]   [Full Text] [Related]  

  • 59. The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease.
    Sarazin M; Lagarde J; El Haddad I; de Souza LC; Bellier B; Potier MC; Bottlaender M; Dorothée G
    Nat Aging; 2024 Jun; 4(6):761-770. PubMed ID: 38839924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug development status for Alzheimer's disease: present scenario.
    Misra S; Medhi B
    Neurol Sci; 2013 Jun; 34(6):831-9. PubMed ID: 23392897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.